nodes	percent_of_prediction	percent_of_DWPC	metapath
Antipyrine—migraine—Prednisone—prostate cancer	0.275	1	CpDpCtD
Antipyrine—CYP2C18—prostate cancer	0.102	0.322	CbGaD
Antipyrine—CYP2A6—prostate cancer	0.0648	0.206	CbGaD
Antipyrine—CYP2E1—prostate cancer	0.046	0.146	CbGaD
Antipyrine—CYP2C19—prostate cancer	0.0455	0.145	CbGaD
Antipyrine—CYP3A4—prostate cancer	0.029	0.0919	CbGaD
Antipyrine—PTGS2—prostate cancer	0.0284	0.09	CbGaD
Antipyrine—CYP2C8—Nilutamide—prostate cancer	0.0152	0.049	CbGbCtD
Antipyrine—CYP2C19—Bicalutamide—prostate cancer	0.0127	0.0411	CbGbCtD
Antipyrine—CYP2C19—Nilutamide—prostate cancer	0.0127	0.0411	CbGbCtD
Antipyrine—CYP2C8—Abiraterone—prostate cancer	0.0126	0.0406	CbGbCtD
Antipyrine—CYP2E1—Estrone—prostate cancer	0.0122	0.0393	CbGbCtD
Antipyrine—CYP2B6—Estrone—prostate cancer	0.012	0.0388	CbGbCtD
Antipyrine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0117	0.0379	CbGbCtD
Antipyrine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0107	0.0346	CbGbCtD
Antipyrine—CYP2C9—Nilutamide—prostate cancer	0.0106	0.0342	CbGbCtD
Antipyrine—CYP2C9—Bicalutamide—prostate cancer	0.0106	0.0342	CbGbCtD
Antipyrine—CYP2C19—Flutamide—prostate cancer	0.0106	0.0341	CbGbCtD
Antipyrine—CYP1A2—Flutamide—prostate cancer	0.00973	0.0315	CbGbCtD
Antipyrine—CYP2D6—Bicalutamide—prostate cancer	0.00968	0.0313	CbGbCtD
Antipyrine—CYP2C8—Cabazitaxel—prostate cancer	0.0093	0.0301	CbGbCtD
Antipyrine—SLC22A6—Conjugated Estrogens—prostate cancer	0.00904	0.0292	CbGbCtD
Antipyrine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0081	0.0262	CbGbCtD
Antipyrine—CYP2D6—Abiraterone—prostate cancer	0.00802	0.0259	CbGbCtD
Antipyrine—CYP2E1—Mitoxantrone—prostate cancer	0.00724	0.0234	CbGbCtD
Antipyrine—CYP1A2—Estrone—prostate cancer	0.00704	0.0227	CbGbCtD
Antipyrine—PTGS2—Etoposide—prostate cancer	0.007	0.0226	CbGbCtD
Antipyrine—CYP2C9—Estrone—prostate cancer	0.00634	0.0205	CbGbCtD
Antipyrine—CYP3A4—Bicalutamide—prostate cancer	0.00616	0.0199	CbGbCtD
Antipyrine—PTGS1—Etoposide—prostate cancer	0.00591	0.0191	CbGbCtD
Antipyrine—CYP3A4—Estramustine—prostate cancer	0.00572	0.0185	CbGbCtD
Antipyrine—CYP2C8—Estradiol—prostate cancer	0.00522	0.0169	CbGbCtD
Antipyrine—CYP3A4—Flutamide—prostate cancer	0.0051	0.0165	CbGbCtD
Antipyrine—CYP3A4—Abiraterone—prostate cancer	0.0051	0.0165	CbGbCtD
Antipyrine—CYP2C9—Capecitabine—prostate cancer	0.00481	0.0155	CbGbCtD
Antipyrine—CYP1A2—Conjugated Estrogens—prostate cancer	0.0046	0.0149	CbGbCtD
Antipyrine—CYP2E1—Etoposide—prostate cancer	0.00456	0.0147	CbGbCtD
Antipyrine—CYP2C19—Estradiol—prostate cancer	0.00438	0.0142	CbGbCtD
Antipyrine—CYP1A2—Estradiol—prostate cancer	0.00404	0.0131	CbGbCtD
Antipyrine—CYP3A4—Cabazitaxel—prostate cancer	0.00377	0.0122	CbGbCtD
Antipyrine—CYP2C19—Prednisone—prostate cancer	0.00377	0.0122	CbGbCtD
Antipyrine—CYP3A4—Estrone—prostate cancer	0.00369	0.0119	CbGbCtD
Antipyrine—CYP2C9—Estradiol—prostate cancer	0.00364	0.0118	CbGbCtD
Antipyrine—CYP2C8—Etoposide—prostate cancer	0.00341	0.011	CbGbCtD
Antipyrine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00329	0.0106	CbGbCtD
Antipyrine—CYP2B6—Doxorubicin—prostate cancer	0.00307	0.00992	CbGbCtD
Antipyrine—CYP1A2—Etoposide—prostate cancer	0.00264	0.00853	CbGbCtD
Antipyrine—TRPA1—prostate gland—prostate cancer	0.00246	0.136	CbGeAlD
Antipyrine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00241	0.00779	CbGbCtD
Antipyrine—CYP3A4—Mitoxantrone—prostate cancer	0.00219	0.00709	CbGbCtD
Antipyrine—CYP3A4—Estradiol—prostate cancer	0.00212	0.00684	CbGbCtD
Antipyrine—CYP3A4—Prednisone—prostate cancer	0.00182	0.00588	CbGbCtD
Antipyrine—TRPA1—renal system—prostate cancer	0.00167	0.0925	CbGeAlD
Antipyrine—CYP2D6—Doxorubicin—prostate cancer	0.00148	0.00479	CbGbCtD
Antipyrine—CYP2C19—urine—prostate cancer	0.00141	0.0778	CbGeAlD
Antipyrine—CYP3A4—Etoposide—prostate cancer	0.00138	0.00447	CbGbCtD
Antipyrine—CYP3A4—Docetaxel—prostate cancer	0.00127	0.00409	CbGbCtD
Antipyrine—CYP1A2—urine—prostate cancer	0.00115	0.0636	CbGeAlD
Antipyrine—CYP2C9—urine—prostate cancer	0.00109	0.0603	CbGeAlD
Antipyrine—CYP2E1—urine—prostate cancer	0.00103	0.0572	CbGeAlD
Antipyrine—CYP3A4—Doxorubicin—prostate cancer	0.000943	0.00305	CbGbCtD
Antipyrine—CYP3A4—urine—prostate cancer	0.000832	0.046	CbGeAlD
Antipyrine—CYP2D6—urine—prostate cancer	0.000819	0.0453	CbGeAlD
Antipyrine—CYP2A6—prostate gland—prostate cancer	0.000786	0.0434	CbGeAlD
Antipyrine—CYP2A6—seminal vesicle—prostate cancer	0.000665	0.0367	CbGeAlD
Antipyrine—Aminophenazone—CYP17A1—prostate cancer	0.000616	0.272	CrCbGaD
Antipyrine—Aminophenazone—CYP2C18—prostate cancer	0.000516	0.228	CrCbGaD
Antipyrine—CYP2E1—prostate gland—prostate cancer	0.000371	0.0205	CbGeAlD
Antipyrine—PTGS1—prostate gland—prostate cancer	0.000358	0.0198	CbGeAlD
Antipyrine—PTGS2—prostate gland—prostate cancer	0.000342	0.0189	CbGeAlD
Antipyrine—CYP2E1—seminal vesicle—prostate cancer	0.000314	0.0174	CbGeAlD
Antipyrine—PTGS1—seminal vesicle—prostate cancer	0.000303	0.0167	CbGeAlD
Antipyrine—CYP2C8—renal system—prostate cancer	0.000301	0.0166	CbGeAlD
Antipyrine—PTGS2—seminal vesicle—prostate cancer	0.000289	0.016	CbGeAlD
Antipyrine—CYP1A2—renal system—prostate cancer	0.000281	0.0156	CbGeAlD
Antipyrine—CYP2B6—renal system—prostate cancer	0.00027	0.0149	CbGeAlD
Antipyrine—PTGS1—epithelium—prostate cancer	0.000263	0.0145	CbGeAlD
Antipyrine—CYP2E1—renal system—prostate cancer	0.000253	0.014	CbGeAlD
Antipyrine—PTGS2—epithelium—prostate cancer	0.000251	0.0139	CbGeAlD
Antipyrine—CYP2E1—urethra—prostate cancer	0.000249	0.0137	CbGeAlD
Antipyrine—PTGS1—renal system—prostate cancer	0.000244	0.0135	CbGeAlD
Antipyrine—PTGS2—renal system—prostate cancer	0.000233	0.0129	CbGeAlD
Antipyrine—Aminophenazone—CYP2C19—prostate cancer	0.000232	0.102	CrCbGaD
Antipyrine—PTGS2—urethra—prostate cancer	0.000229	0.0127	CbGeAlD
Antipyrine—CYP3A4—renal system—prostate cancer	0.000204	0.0113	CbGeAlD
Antipyrine—CYP2D6—renal system—prostate cancer	0.0002	0.0111	CbGeAlD
Antipyrine—CYP2C8—testis—prostate cancer	0.000194	0.0107	CbGeAlD
Antipyrine—Clobazam—CYP2C18—prostate cancer	0.000182	0.0802	CrCbGaD
Antipyrine—PTGS2—bone marrow—prostate cancer	0.000176	0.00974	CbGeAlD
Antipyrine—CYP2B6—testis—prostate cancer	0.000174	0.00964	CbGeAlD
Antipyrine—Methsuximide—CYP2C19—prostate cancer	0.000169	0.0748	CrCbGaD
Antipyrine—Phensuximide—CYP2C19—prostate cancer	0.000164	0.0724	CrCbGaD
Antipyrine—CYP2E1—testis—prostate cancer	0.000164	0.00904	CbGeAlD
Antipyrine—PTGS1—testis—prostate cancer	0.000158	0.00871	CbGeAlD
Antipyrine—Aminophenazone—CYP3A4—prostate cancer	0.000147	0.065	CrCbGaD
Antipyrine—CYP2D6—testis—prostate cancer	0.00013	0.00716	CbGeAlD
Antipyrine—PTGS1—lymph node—prostate cancer	0.000114	0.00632	CbGeAlD
Antipyrine—PTGS2—lymph node—prostate cancer	0.000109	0.00604	CbGeAlD
Antipyrine—Methylphenobarbital—CYP2C19—prostate cancer	0.000106	0.0467	CrCbGaD
Antipyrine—Clobazam—CYP2C19—prostate cancer	8.14e-05	0.0359	CrCbGaD
Antipyrine—Clobazam—CYP3A4—prostate cancer	5.18e-05	0.0229	CrCbGaD
Antipyrine—CYP2D6—Metabolism—NCOA1—prostate cancer	1.29e-06	1.61e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—COMT—prostate cancer	1.28e-06	1.6e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—GSTP1—prostate cancer	1.27e-06	1.6e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—NCOA1—prostate cancer	1.27e-06	1.6e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.27e-06	1.59e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.27e-06	1.59e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MAP2K1—prostate cancer	1.27e-06	1.58e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—CAV1—prostate cancer	1.26e-06	1.58e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—PIK3CD—prostate cancer	1.26e-06	1.57e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.26e-06	1.57e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.26e-06	1.57e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—ITPR1—prostate cancer	1.25e-06	1.57e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PIK3CD—prostate cancer	1.25e-06	1.57e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—NOS3—prostate cancer	1.25e-06	1.57e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—MED12—prostate cancer	1.25e-06	1.57e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.24e-06	1.56e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—SERPINE1—prostate cancer	1.24e-06	1.56e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GNG5—prostate cancer	1.24e-06	1.55e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—CAV1—prostate cancer	1.24e-06	1.55e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—ERCC2—prostate cancer	1.23e-06	1.54e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.23e-06	1.54e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—SLC5A5—prostate cancer	1.23e-06	1.54e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—RXRA—prostate cancer	1.22e-06	1.53e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—RXRA—prostate cancer	1.21e-06	1.52e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.2e-06	1.51e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—FGF2—prostate cancer	1.2e-06	1.51e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PIK3CG—prostate cancer	1.2e-06	1.5e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NCOA3—prostate cancer	1.2e-06	1.5e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—NQO1—prostate cancer	1.19e-06	1.49e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—NOS3—prostate cancer	1.19e-06	1.49e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—TYMS—prostate cancer	1.19e-06	1.48e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—NOS3—prostate cancer	1.18e-06	1.48e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.18e-06	1.48e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—COMT—prostate cancer	1.18e-06	1.47e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—TH—prostate cancer	1.17e-06	1.47e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—GSTP1—prostate cancer	1.17e-06	1.47e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—GSTM1—prostate cancer	1.17e-06	1.47e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—COMT—prostate cancer	1.17e-06	1.46e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.17e-06	1.46e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—GSTP1—prostate cancer	1.16e-06	1.45e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.16e-06	1.45e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—MTHFR—prostate cancer	1.16e-06	1.45e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PIK3CB—prostate cancer	1.16e-06	1.45e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.16e-06	1.45e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—JAK2—prostate cancer	1.15e-06	1.44e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—ITPR1—prostate cancer	1.15e-06	1.44e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PIK3CG—prostate cancer	1.15e-06	1.44e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—LPL—prostate cancer	1.15e-06	1.44e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PTGS2—prostate cancer	1.15e-06	1.43e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—ITPR1—prostate cancer	1.14e-06	1.43e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.14e-06	1.43e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—HPGDS—prostate cancer	1.14e-06	1.43e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PPARA—prostate cancer	1.14e-06	1.42e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—INS—prostate cancer	1.13e-06	1.42e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.13e-06	1.42e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.13e-06	1.41e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MDM2—prostate cancer	1.13e-06	1.41e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.12e-06	1.41e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.11e-06	1.39e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—CREBBP—prostate cancer	1.11e-06	1.39e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—ERBB2—prostate cancer	1.11e-06	1.39e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ACHE—prostate cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GSTT1—prostate cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GGT1—prostate cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—ERCC2—prostate cancer	1.1e-06	1.38e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—PIK3CB—prostate cancer	1.1e-06	1.37e-05	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—PIK3CA—prostate cancer	1.09e-06	1.37e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PIK3CB—prostate cancer	1.09e-06	1.37e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.09e-06	1.37e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—TYMS—prostate cancer	1.09e-06	1.36e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—INS—prostate cancer	1.09e-06	1.36e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—NCOA1—prostate cancer	1.09e-06	1.36e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PTGS2—prostate cancer	1.08e-06	1.36e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—TYMS—prostate cancer	1.08e-06	1.35e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—GSTM1—prostate cancer	1.08e-06	1.35e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.07e-06	1.34e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—CAV1—prostate cancer	1.07e-06	1.34e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—GSTM1—prostate cancer	1.07e-06	1.34e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—CREBBP—prostate cancer	1.07e-06	1.34e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—INS—prostate cancer	1.07e-06	1.34e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.06e-06	1.33e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PRKACB—prostate cancer	1.06e-06	1.32e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—LPL—prostate cancer	1.06e-06	1.32e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PIK3CD—prostate cancer	1.05e-06	1.32e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—LPL—prostate cancer	1.05e-06	1.31e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.05e-06	1.31e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—CREBBP—prostate cancer	1.05e-06	1.31e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—RXRA—prostate cancer	1.04e-06	1.3e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—MTHFR—prostate cancer	1.04e-06	1.3e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CDKN1B—prostate cancer	1.03e-06	1.29e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.02e-06	1.28e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.02e-06	1.28e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PPARA—prostate cancer	1.02e-06	1.27e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—ERCC2—prostate cancer	1.01e-06	1.27e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.01e-06	1.27e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PIK3CD—prostate cancer	1.01e-06	1.27e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.01e-06	1.26e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—ERCC2—prostate cancer	1e-06	1.26e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PTEN—prostate cancer	9.99e-07	1.25e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—COMT—prostate cancer	9.98e-07	1.25e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NCOA2—prostate cancer	9.97e-07	1.25e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—NOS3—prostate cancer	9.94e-07	1.24e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GSTP1—prostate cancer	9.93e-07	1.24e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PIK3CD—prostate cancer	9.91e-07	1.24e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ITPR1—prostate cancer	9.77e-07	1.22e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PIK3CG—prostate cancer	9.74e-07	1.22e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CTNNB1—prostate cancer	9.71e-07	1.22e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.61e-07	1.2e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—NOS3—prostate cancer	9.55e-07	1.2e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CAV1—prostate cancer	9.55e-07	1.2e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—EP300—prostate cancer	9.53e-07	1.19e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—MTHFR—prostate cancer	9.52e-07	1.19e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—SLC5A5—prostate cancer	9.52e-07	1.19e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CDKN1A—prostate cancer	9.49e-07	1.19e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—PTEN—prostate cancer	9.47e-07	1.18e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PTEN—prostate cancer	9.45e-07	1.18e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—MTHFR—prostate cancer	9.44e-07	1.18e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—NOS3—prostate cancer	9.36e-07	1.17e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PPARA—prostate cancer	9.34e-07	1.17e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYP2E1—prostate cancer	9.29e-07	1.16e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PPARA—prostate cancer	9.26e-07	1.16e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—TYMS—prostate cancer	9.23e-07	1.16e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—INS—prostate cancer	9.22e-07	1.15e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NQO1—prostate cancer	9.19e-07	1.15e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PIK3CB—prostate cancer	9.18e-07	1.15e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GSTM1—prostate cancer	9.13e-07	1.14e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.12e-07	1.14e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—TH—prostate cancer	9.06e-07	1.13e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—CREBBP—prostate cancer	9.03e-07	1.13e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—EP300—prostate cancer	9.03e-07	1.13e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—EP300—prostate cancer	9.01e-07	1.13e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—LPL—prostate cancer	8.96e-07	1.12e-05	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—AKT1—prostate cancer	8.93e-07	1.12e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PIK3CB—prostate cancer	8.82e-07	1.1e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYP1B1—prostate cancer	8.81e-07	1.1e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CAV1—prostate cancer	8.78e-07	1.1e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—SRC—prostate cancer	8.78e-07	1.1e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PTGS2—prostate cancer	8.74e-07	1.09e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CAV1—prostate cancer	8.71e-07	1.09e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PIK3CG—prostate cancer	8.7e-07	1.09e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CYP1A1—prostate cancer	8.65e-07	1.08e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PIK3CB—prostate cancer	8.64e-07	1.08e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ERCC2—prostate cancer	8.58e-07	1.07e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PIK3CD—prostate cancer	8.57e-07	1.07e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PTGS2—prostate cancer	8.56e-07	1.07e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GGT1—prostate cancer	8.53e-07	1.07e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—STAT3—prostate cancer	8.47e-07	1.06e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NCOA1—prostate cancer	8.41e-07	1.05e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.32e-07	1.04e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYP19A1—prostate cancer	8.28e-07	1.04e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—INS—prostate cancer	8.23e-07	1.03e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—NOS3—prostate cancer	8.09e-07	1.01e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—MTHFR—prostate cancer	8.07e-07	1.01e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CREBBP—prostate cancer	8.06e-07	1.01e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PIK3CG—prostate cancer	8e-07	1e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—RXRA—prostate cancer	7.99e-07	1e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PIK3CG—prostate cancer	7.93e-07	9.93e-06	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PTEN—prostate cancer	7.93e-07	9.92e-06	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PPARA—prostate cancer	7.91e-07	9.9e-06	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MYC—prostate cancer	7.87e-07	9.85e-06	CbGpPWpGaD
Antipyrine—PTGS2—Disease—TGFB1—prostate cancer	7.85e-07	9.82e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—COMT—prostate cancer	7.7e-07	9.64e-06	CbGpPWpGaD
Antipyrine—PTGS2—Disease—EGFR—prostate cancer	7.7e-07	9.63e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GSTP1—prostate cancer	7.67e-07	9.59e-06	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PIK3CD—prostate cancer	7.65e-07	9.57e-06	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PTEN—prostate cancer	7.62e-07	9.54e-06	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—INS—prostate cancer	7.57e-07	9.48e-06	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—EP300—prostate cancer	7.56e-07	9.46e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ITPR1—prostate cancer	7.54e-07	9.44e-06	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—INS—prostate cancer	7.51e-07	9.4e-06	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PIK3CB—prostate cancer	7.47e-07	9.34e-06	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PTEN—prostate cancer	7.46e-07	9.34e-06	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CAV1—prostate cancer	7.44e-07	9.31e-06	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CREBBP—prostate cancer	7.42e-07	9.28e-06	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PTGS2—prostate cancer	7.4e-07	9.26e-06	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CREBBP—prostate cancer	7.35e-07	9.2e-06	CbGpPWpGaD
Antipyrine—PTGS2—Disease—KRAS—prostate cancer	7.27e-07	9.1e-06	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—EP300—prostate cancer	7.27e-07	9.1e-06	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—NOS3—prostate cancer	7.22e-07	9.04e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—TYMS—prostate cancer	7.13e-07	8.92e-06	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—EP300—prostate cancer	7.12e-07	8.91e-06	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.11e-07	8.9e-06	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PIK3CA—prostate cancer	7.05e-07	8.82e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GSTM1—prostate cancer	7.04e-07	8.82e-06	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PIK3CD—prostate cancer	7.03e-07	8.8e-06	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PIK3CD—prostate cancer	6.97e-07	8.73e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—LPL—prostate cancer	6.91e-07	8.65e-06	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PIK3CG—prostate cancer	6.78e-07	8.48e-06	CbGpPWpGaD
Antipyrine—PTGS2—Disease—PIK3CA—prostate cancer	6.68e-07	8.36e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYP1A1—prostate cancer	6.68e-07	8.36e-06	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PIK3CB—prostate cancer	6.66e-07	8.34e-06	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PIK3CA—prostate cancer	6.66e-07	8.34e-06	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—NOS3—prostate cancer	6.64e-07	8.31e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ERCC2—prostate cancer	6.62e-07	8.29e-06	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PTGS2—prostate cancer	6.6e-07	8.26e-06	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—NOS3—prostate cancer	6.58e-07	8.24e-06	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PTEN—prostate cancer	6.45e-07	8.07e-06	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—INS—prostate cancer	6.42e-07	8.03e-06	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CREBBP—prostate cancer	6.28e-07	7.86e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—MTHFR—prostate cancer	6.23e-07	7.79e-06	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—EP300—prostate cancer	6.15e-07	7.7e-06	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PIK3CB—prostate cancer	6.13e-07	7.67e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PPARA—prostate cancer	6.11e-07	7.64e-06	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PIK3CB—prostate cancer	6.08e-07	7.61e-06	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PTGS2—prostate cancer	6.07e-07	7.6e-06	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PTGS2—prostate cancer	6.02e-07	7.54e-06	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PIK3CD—prostate cancer	5.96e-07	7.46e-06	CbGpPWpGaD
Antipyrine—PTGS2—Disease—IL6—prostate cancer	5.91e-07	7.4e-06	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PTEN—prostate cancer	5.76e-07	7.21e-06	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—AKT1—prostate cancer	5.76e-07	7.2e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CAV1—prostate cancer	5.74e-07	7.19e-06	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—NOS3—prostate cancer	5.63e-07	7.04e-06	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PIK3CA—prostate cancer	5.59e-07	7e-06	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—EP300—prostate cancer	5.49e-07	6.87e-06	CbGpPWpGaD
Antipyrine—PTGS2—Disease—AKT1—prostate cancer	5.46e-07	6.83e-06	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—AKT1—prostate cancer	5.44e-07	6.81e-06	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PIK3CA—prostate cancer	5.38e-07	6.73e-06	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PTEN—prostate cancer	5.3e-07	6.63e-06	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PIK3CA—prostate cancer	5.27e-07	6.59e-06	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PTEN—prostate cancer	5.25e-07	6.57e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PIK3CG—prostate cancer	5.23e-07	6.55e-06	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PIK3CB—prostate cancer	5.19e-07	6.5e-06	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PTGS2—prostate cancer	5.15e-07	6.44e-06	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—EP300—prostate cancer	5.05e-07	6.32e-06	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—EP300—prostate cancer	5.01e-07	6.27e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—INS—prostate cancer	4.95e-07	6.2e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CREBBP—prostate cancer	4.85e-07	6.07e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.6e-07	5.75e-06	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—AKT1—prostate cancer	4.57e-07	5.72e-06	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PIK3CA—prostate cancer	4.55e-07	5.7e-06	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PTEN—prostate cancer	4.49e-07	5.62e-06	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—AKT1—prostate cancer	4.39e-07	5.5e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NOS3—prostate cancer	4.34e-07	5.43e-06	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—AKT1—prostate cancer	4.3e-07	5.38e-06	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—EP300—prostate cancer	4.28e-07	5.36e-06	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PIK3CA—prostate cancer	4.06e-07	5.08e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PIK3CB—prostate cancer	4.01e-07	5.02e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PTGS2—prostate cancer	3.97e-07	4.97e-06	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PIK3CA—prostate cancer	3.74e-07	4.68e-06	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—AKT1—prostate cancer	3.72e-07	4.65e-06	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.7e-07	4.64e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PTEN—prostate cancer	3.46e-07	4.33e-06	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—AKT1—prostate cancer	3.32e-07	4.15e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—EP300—prostate cancer	3.3e-07	4.13e-06	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PIK3CA—prostate cancer	3.17e-07	3.96e-06	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—AKT1—prostate cancer	3.05e-07	3.82e-06	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—AKT1—prostate cancer	3.03e-07	3.79e-06	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—AKT1—prostate cancer	2.59e-07	3.24e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.44e-07	3.06e-06	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—AKT1—prostate cancer	2e-07	2.5e-06	CbGpPWpGaD
